iShares Biotechnology ETF
IBB
IBB
306 hedge funds and large institutions have $4.42B invested in iShares Biotechnology ETF in 2014 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 81 increasing their positions, 117 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
306
Holders Change
+18
Holders Change %
+6.25%
% of All Funds
8.8%
Holding in Top 10
14
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-30%
% of All Funds
0.4%
New
60
Increased
81
Reduced
117
Closed
41
Calls
$439M
Puts
$675M
Net Calls
-$236M
Net Calls Change
-$115M
Top Buyers
1 |
Goldman Sachs
New York
|
$863M |
2 |
Morgan Stanley
New York
|
$573M |
3 |
SG Americas Securities
New York
|
$59.9M |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$80.7M |
5 |
HI
Honeywell International
Charlotte,
North Carolina
|
$19.3M |